These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29878459)

  • 1. Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock.
    Bauer SR; Sacha GL; Lam SW
    Pharmacotherapy; 2018 Aug; 38(8):851-861. PubMed ID: 29878459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
    McIntyre WF; Um KJ; Alhazzani W; Lengyel AP; Hajjar L; Gordon AC; Lamontagne F; Healey JS; Whitlock RP; Belley-Côté EP
    JAMA; 2018 May; 319(18):1889-1900. PubMed ID: 29801010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
    Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
    J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
    Allen JM; Gilbert BW
    Clin Ther; 2019 Dec; 41(12):2594-2610. PubMed ID: 31668356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.
    Puntillo F; Giglio M; Pasqualucci A; Brienza N; Paladini A; Varrassi G
    Adv Ther; 2020 Sep; 37(9):3692-3706. PubMed ID: 32705530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasopressin and its analogues in the therapy of shock].
    Novák F; Lubanda H; Onderková R; Zák A
    Cas Lek Cesk; 2004; 143(5):307-8, 310-2. PubMed ID: 15305765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II (Giapreza) for septic shock.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):199-200. PubMed ID: 30653477
    [No Abstract]   [Full Text] [Related]  

  • 12. A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock.
    Bissell BD; Browder K; McKenzie M; Flannery AH
    Ann Pharmacother; 2018 Sep; 52(9):920-927. PubMed ID: 29582666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous Vasopressin-Induced Hyponatremia in Patients With Vasodilatory Shock: Two Case Reports and Literature Review.
    Salazar M; Hu BB; Vazquez J; Wintz RL; Varon J
    J Intensive Care Med; 2015 Jul; 30(5):253-8. PubMed ID: 24106070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects!
    Angstwurm M
    Crit Care Med; 2005 Nov; 33(11):2713-4. PubMed ID: 16276218
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasopressin for treatment of hemodynamic disorders].
    Adukauskiene D; Sirvinskas E; Kevelaitis E
    Medicina (Kaunas); 2008; 44(2):167-73. PubMed ID: 18344670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is vasopressin increasing or decreasing mortality in patients with septic shock?
    Rehberg S; Ertmer C; Van Aken H; Westphal M
    Surg Infect (Larchmt); 2008 Apr; 9(2):215 author reply 216. PubMed ID: 18426355
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin II for the Treatment of Vasodilatory Shock.
    Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM;
    N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than skin deep? Complications associated with vasopressin infusion: a cautionary tale.
    Mariscalco MM
    Crit Care Med; 2003 May; 31(5):1587-8. PubMed ID: 12771642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.